ZYMEWORKS INC. - COMMON STOCK

Zymeworks To Host Third Quarter 2023 Results Conference Call

17 окт 2023 08:30:02 Источник Nasdaq GlobeNewswire

Zymeworks Announces New Director Nominee

16 окт 2023 16:30:18 Источник Nasdaq GlobeNewswire

Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results

10 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

01 авг 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks To Host Second Quarter 2023 Results Conference Call

19 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conference

03 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks Appoints New Director

29 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire

Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

26 июн 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

01 июн 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer

18 май 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results

08 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

01 май 2023 08:30:00 Источник Nasdaq GlobeNewswire

Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting

18 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire